Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

RVTY

Revvity (RVTY)

Revvity Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:RVTY
DateHeureSourceTitreSymboleSociété
20/11/202414h00Business WireRevvity Broadens Relationship with Genomics England to Advance Genomics in the UKNYSE:RVTYRevvity Inc
19/11/202414h00Business WireScale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsNYSE:RVTYRevvity Inc
19/11/202414h00Business WireRevvity to Present at 7th Annual Evercore ISI HealthCONx ConferenceNYSE:RVTYRevvity Inc
18/11/202414h00Business WireRevvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationNYSE:RVTYRevvity Inc
14/11/202422h30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:RVTYRevvity Inc
14/11/202419h22Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:RVTYRevvity Inc
06/11/202422h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RVTYRevvity Inc
04/11/202412h11Edgar (US Regulatory)Form 8-K - Current reportNYSE:RVTYRevvity Inc
04/11/202412h00Business WireRevvity Announces Financial Results for the Third Quarter of 2024NYSE:RVTYRevvity Inc
24/10/202422h05Business WireRevvity Board Declares Quarterly DividendNYSE:RVTYRevvity Inc
22/10/202415h00Business WireRevvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical LaboratoriesNYSE:RVTYRevvity Inc
22/10/202414h00Business WireRevvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact ReportNYSE:RVTYRevvity Inc
10/10/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RVTYRevvity Inc
09/10/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RVTYRevvity Inc
07/10/202423h21Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NYSE:RVTYRevvity Inc
07/10/202414h00Business WireRevvity To Hold Earnings Call on Monday, November 4, 2024NYSE:RVTYRevvity Inc
02/10/202414h00Business WireRevvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE GeneNYSE:RVTYRevvity Inc
21/08/202414h00Business WireRevvity to Present at Upcoming Investor ConferencesNYSE:RVTYRevvity Inc
29/07/202412h00Business WireRevvity Announces Financial Results for the Second Quarter of 2024NYSE:RVTYRevvity Inc
09/07/202414h00Business WireRevvity To Hold Earnings Call on Monday, July 29, 2024NYSE:RVTYRevvity Inc
20/06/202414h00GlobeNewswire Inc.Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchNYSE:RVTYRevvity Inc
31/05/202414h00Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:RVTYRevvity Inc
28/05/202414h00Business WireRevvity to Present at Goldman Sachs Global Healthcare ConferenceNYSE:RVTYRevvity Inc
29/04/202412h00Business WireRevvity Announces Financial Results for the First Quarter of 2024NYSE:RVTYRevvity Inc
25/04/202414h00Business WireRevvity to Present at BofA Securities 2024 Health Care ConferenceNYSE:RVTYRevvity Inc
24/04/202412h00Business WireRevvity Unveils a New Era of Automated Tuberculosis TestingNYSE:RVTYRevvity Inc
15/04/202412h00Business WireRevvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersNYSE:RVTYRevvity Inc
04/04/202414h00Business WireRevvity To Hold Earnings Call on Monday, April 29, 2024NYSE:RVTYRevvity Inc
02/04/202412h00Business WirePreliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire SoftwareNYSE:RVTYRevvity Inc
20/03/202422h00Business WireRevvity Files Complaint and Seeks Injunctive Relief Against Cloud Software GroupNYSE:RVTYRevvity Inc
 Showing the most relevant articles for your search:NYSE:RVTY